Back to search

France· FR:60642949

ZOPICLONE ARROW LAB 7,5 mg, comprimé pelliculé sécable

A zopiclone product containing zopiclone, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N05CF01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedZOPICLONE ARROW LAB 7,5 mg, comprimé …ATCN05CF01REGISTER NO.FR:60642949PACKS LISTED3CHECKEDSeptember 12, 2026

Where it is registered

Zopiclone is registered in 16 of 19 countries.

Countries holding a registration under ATC N05CF01 (zopiclone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Zopiclone · ATC N05CF01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of zopiclone costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.22 in France to $1.09 in Switzerland — a ×5.0 gap.

  • France: $0.22 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Zopiclone · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.09
  • FR France$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ZOPICLONE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
N05CF01
ATC class
Zopiclone
Defined daily dose
7.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

2 priced
  • cip13
    3400930152720
    plaquette(s) PVC aluminium de 5 comprimé(s)
    EUR 0.95
  • cip13
    3400930152744
    plaquette(s) PVC aluminium de 14 comprimé(s)
    EUR 1.83
  • cip13
    3400955057123
    plaquette(s) PVC aluminium de 60 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for zopiclone.

Graded by severity as the source publishes them — 156 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Zopiclone · interactions on record

166 records

  • 156 info

Most severe, free to view

    10 more interactions with mechanism and management, from a commercially licensed source.

    Sign in to check
    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Zopiclone in 14 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All zopiclone products

    Authorised across Europe · EMA

    The same active substance is authorised in 27 EEA countries. Names it is sold under:

    • Austria · Somnal Stada Arzneimittel, Zopiclon Grindeks
    • Belgium · Imovane, Zopiclone Ab
    • Bulgaria · Екодорм, Зопиклон Гриндекс
    • Czechia · Zopiclone Grindeks, Zopiclone Olpha
    • Germany · Ximovan, Zopiclodura
    • Denmark · Imozop, Somnols
    • Estonia · Imovane, Somnols
    • Spain · Limován
    • Finland · Imovane, Zopiclone Grindeks
    • United Kingdom (Northern Ireland) · Zimovane, Zopiclone
    • Greece · Imovane
    • Croatia · Zonotte, Zopiklon Grindeks
    • Hungary · Imovane, Somnol
    • Ireland · Zimoclone, Zimovane
    • Iceland · Imomed, Imovane
    • Italy · Imovane, Zopiclone Aristo
    • Lithuania · Somnols, Zopiclone Eletis
    • Luxembourg · Imovane, Zopiclone Eg
    • Latvia · Imovane, Somnols
    • Netherlands · Zopiclon Cf, Zopiclon Grindeks
    • Norway · Imovane, Sonlax
    • Poland · Apodream, Dobroson
    • Portugal · Zopiclona Grindeks
    • Romania · Imovane, Sonlax
    • Sweden · Imovane, Zopiclon Stada
    • Slovenia · Maknotte, Zopiklon Grindeks
    • Slovakia · Somnols, Sonlax

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/a9bcd366-2655-4c9b-913e-7ecfbaa8e635
    GET /v1/drugs/a9bcd366-2655-4c9b-913e-7ecfbaa8e635?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
      "cis": "60642949",
      "date_amm": "2018-07-04",
      "type_amm": "Procédure décentralisée",
      "numero_ue": null,
      "substance": "ZOPICLONE",
      "atc_source": "fr_atc_restore_2026-09-06",
      "statut_amm": "Autorisation active",
      "statut_bdm": null,
      "forme_pharmaceutique": "comprimé pelliculé sécable",
      "voies_administration": "orale",
      "etat_commercialisation": "Commercialisée",
      "surveillance_renforcee": "Non"
    }

    See everything about zopiclone.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.